Multimerization domains for antibody phage display and antibody production

New Biotechnology

Volumn 26, Issue 6, 2009, Pages 314-321

  Thie, H ^a   Binius, S ^a,b   Schirrmann, T ^a   Hust, M ^a   Dubel S ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY COMPLEXES; ANTIBODY FRAGMENT; ANTIBODY GENES; ANTIBODY PRODUCTION; BIOTIN ACCEPTOR; BIOTINYLATIONS; HIGH-THROUGHPUT; IN-VITRO; IN-VIVO; KEY PARAMETERS; MULTIMERIC; MULTIMERIZATION; PHAGE DISPLAY; PRODUCTION YIELD;

OLIGOMERIZATION; OLIGOMERS;

ANTIBODIES;

ANTIBODY; ANTIGEN; PEPTIDE FRAGMENT; PEPTIDE LIBRARY; STREPTAVIDIN;

ANTIBODY PRODUCTION; ARTICLE; CHEMISTRY; ESCHERICHIA COLI; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SOLUBILITY;

ANTIBODIES; ANTIBODY FORMATION; ANTIGENS; ESCHERICHIA COLI; IMMUNOGLOBULIN VARIABLE REGION; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SOLUBILITY; STREPTAVIDIN;

EID: 77952243564     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2009.07.005     Document Type: Article

References (29)

1. McCafferty J., et al. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990, 348:552-554.
2. Breitling F., et al. A surface expression vector for antibody screening. Gene 1991, 104:147-153.
3. Schirrmann T., et al. Production systems for recombinant antibodies. Front. Biosci. 2008, 13:4576-4594.
4. Marks J.D., et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 1991, 222:581-597.
5. Kirsch M.I., et al. Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol. 2008, 8:66.
6. Karush F. Affinity and the immune response. Ann. N. Y. Acad. Sci. 1970, 169:56-64.
7. Holliger P., et al. " Diabodies" : small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:6444-6448.
8. Iliades P., et al. Triabodies: single chain Fv fragments without a linker form trivalent trimers. FEBS Lett. 1997, 409:437-441.
9. Le Gall F., et al. Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett. 1999, 453:164-168.
10. Gruber M., et al. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J. Immunol. 1994, 152:5368-5374.
11. Shu L., et al. Secretion of a single-gene-encoded immunoglobulin from myeloma cells. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7995-7999.
12. Hu S., et al. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 1996, 56:3055-3061.
13. Plückthun A., Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology 1997, 3:83-105.
14. Rheinnecker M., et al. Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J. Immunol. 1996, 157:2989-2997.
15. Schatz P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (N Y) 1993, 11:1138-1143.
16. Kipriyanov S.M., et al. Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen. Hum. Antibodies Hybridomas 1995, 6:93-101.
17. Cloutier S.M., et al. Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Mol. Immunol. 2000, 37:1067-1077.
18. Hust M., et al. Single chain Fab (scFab) fragment. BMC Biotechnol. 2007, 7:14.
19. Vieira J., Messing J. Production of single-stranded plasmid DNA. Methods Enzymol. 1987, 153:3-11.
20. Grote A., et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005, 33(Web Server issue):W526-W531.
21. Kirsch M., et al. Parameters affecting the display of antibodies on phage. J. Immunol. Methods 2005, 301:173-185.
22. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press. 3rd edn.
23. Schmiedl A., et al. Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli. J. Immunol. Methods 2000, 242:101-114.
24. Hust M., Dübel S. Mating antibody phage display with proteomics. Trends Biotechnol. 2004, 22:8-14.
25. Taussig M.J., et al. Proteome binders: planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 2007, 4:13-17.
26. Lee C.V., et al. Bivalent antibody phage display mimics natural immunoglobulin. J. Immunol. Methods 2004, 284:119-132.
27. Willuda J., et al. Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides. J. Biol. Chem. 2001, 276:14385-14392.
28. Pack P., et al. Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J. Mol. Biol. 1995, 246:28-34.
29. Arndt K.M., et al. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry 1998, 37:12918-12926.